Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by blartaron Aug 13, 2013 5:44pm
192 Views
Post# 21667659

RE:Bioniche shareholders upset at plan

RE:Bioniche shareholders upset at planRead this and weep. Belliville Intelligencer Aug.10 2013

                                  

McRae admitted Bioniche's viability hinges on Urocidin.

“That (failure) would be terrible,” McRae said. Bioniche recorded about $30 million in revenue for 2012, while shouldering a $55-million debt load. The value of Bioniche shares have plummeted from $5 to the current trading rate of about 33 cents

McRae anticipate it could take another two years before Urocidin is ready for sale, Gubitz contend it could take up to five years.

“I view it as irresponsible for someone to say it's going to get to market,” Gubitz said.


<< Previous
Bullboard Posts
Next >>